Clinical Trials

    SPHERE Per-AF Post-Approval Study

    Investigator: Miguel Valderrabano

    Study Coordinator: Chinwe Ngumezi

    Status: Enrolling

    ClinicalTrials.gov Number: NCT06858306

    Phone: 346.238.0290

    Protocol Number: PRO00040863

    Description


    SPHERE Per-AF Post-Approval Study is a prospective, multi-center, non-randomized, observational trial. Subjects will be treated with the Sphere-9™ Catheter and Affera™ Ablation System and followed through 36 months.